Occurrence of subnormal corpus luteum in superovulated Santa Inês sheep using protocols with or without LH administrated at the end of the FSH treatment. by OLIVEIRA, M. E. F. et al.
 Abstracts. II International Symposium on Animal Biology of Reproduction, Nov. 19-22, 2008, São Paulo, SP, Brazil.  
 
Anim. Reprod., v.6, n.1, p.231, Jan./Mar. 2009 231
Occurrence of subnormal corpus luteum in superovulated Santa Inês sheep using protocols 
with or without LH administrated at the end of the FSH treatment 
 
M.E.F. Oliveira¹, J.F. Fonseca2, J.S.P. Pieroni¹, R.M. Ferreira¹, M.F. Cordeiro¹, S.F. Souza¹, 
P.P.M. Teixeira¹, W.R.R. Vicente¹ 
 
¹DMVPRA, FCAV, UNESP, 14884-900, Jaboticabal  SP, Brazil; ²EMBRAPA, CNPC, Sobral  CE, Brazil 
 
Introduction 
Corpora lutea (CL) that are small (<5mm), grossly pale, with little or no protrusion from the surface of the ovary are 
defined as subnormal and are associated to low circulating progesterone concentrations. The formation of a 
subnormal or short-lived CL has been widely reported in superovulated sheep (1). Two causes of subnormal CL 
formation have been proposed: i) inadequate follicle development preceding luteal gland formation (2), and ii) 
premature activation of the luteolytic mechanism (3). Based on the latter possibility in practice, luteolytic inhibitors 
such as Flunixine Meglumine are used. Thus, the objective of the present study was to evaluate the occurrence of 
subnormal CL in superovulated Santa Inês sheep using protocols with or without LH administrated at the end of the 
FSH treatment.  
 
Materials and Methods 
Twenty multiple ovulations were accomplished and the experiment was designed as a 2 by 2 factorial, with the main 
effects of replicate and treatment. The estrus was synchronized with a progesterone-releasing intravaginal device 
(CIDR; Pfizer-New Zealand) inserted on Day 0, replaced by a new one that was maintained from Day 7 to Day 14. 
Two doses of the 37.5 µg of D-cloprostenol (Prolise, Arsa - Argentina) were administered, IM, on Day 7 and 14. 
Then, 256 mg of FSHp (Folltropin, Bioniche-Canada) were administrated in 8 decreasing doses, starting on Day 
12. On Day 14, all females received 200 IU of eCG (Novormon, Syntex-Argentina). On Day 15, the animals were 
homogeneously allocated in one of the two experimental groups: Control (GC) and treated (G-LH). Sheep in GC did 
not receive exogenous LH, while sheep in G-LH were treated with 7.5 mg of LH (Lutropin, Bioniche-Canada), 24 
h after device withdrawal (Day 15). On Day 16, the number of ovulatory follicles was verified by laparoscopy. On 
Day 17, 18 and 19, all females received 75 mg of Flunixine meglumine (Banamine, Shering-Plough, Brazil). On 
Day 21, the ovarian structures were evaluated by laparoscopy. Number of normal CL, subnormal CL and 
anovulatory follicles were measured. Two-way analysis was run for the effects of replicate (2 replicates) and groups 
(GC and G-LH). Data were analyzed using by ANOVA using procedure GLM of SAS, and means (±SD) were 
compared using Kruskal-Wallis test (P < 0.05). 
 
Results and Discussion 
Ovulation rate tended to be increased in G-LH (85.44% vs 77.77%, P = 0.08). The number of CL (mean ± SD) was 
10.5 ± 3.8 in GC and 13.5 ± 4.84 in G-LH; P > 0.1. There was not effect of replicate evaluating the number of CL in 
GC (12 ± 3.46 vs 9 ± 3.87); whereas in G-LH there was a negative effect (16.6 ± 2.97 vs 10.4 ± 4.45). The number 
of anovulatory follicles did not differ statistically between groups (GC: 3.0 ± 3.19; G-LH: 2.3 ± 1.63). Likewise, no 
effect of repeatability was shown for this variable. The anovulatory rate tended to decrease in G-LH (22.22% vs 
14.55%, P = 0.08). Even using Flunixine Meglunine to prevent luteolysis, 20% of the ewes treated with GC 
and 40% of the ewes in G-LH presented at least one subnormal CL (P > 0.05). The numbers of subnormal CL 
were 3.0 ± 1.41 for GC and 1.25 ± 0.5 for G-LH (P > 0.1). Failure in formation of CLs was not punctual 
characteristic because it was found that a single female had normal and subnormal CL. These data does not 
corroborate with data published by Rubianes et al. (1996). The subnormal CLs were observed just in second 
replicate of each female. This fact suggests that the repeatability of treatment could have interfered in formation of 
CL, however, statistical difference was observed just for number of subnormal CL in G-LH. The greater number of 
subnormal CL in G-LH in the second reply might have been caused by the administration of LH, which can induce 
the ovulation of a follicle without appropriate capacity of formation of a CL.  Indeed, a previous study showed that 
GnRH administration when follicles are not completely maturated induce the formation of CL without adequate function 
or short lived (4). The results showed that the formation of a subnormal or a short-lived CL can be more related to the 
incapacity of the ovulated follicle to form a normal CL than to the premature activation of luteolytic mechanism. 
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